Accession Number : AD1012682

Title :   Periodontal Regeneration Of 1-, 2-, and 3-Walled Intrabony Defects Using Accell Connexus (registered trademark) Versus Demineralized Freeze-Dried Bone Allograft: A Randomized Parallel Arm Clinical Control Trial

Descriptive Note : Technical Report

Corporate Author : Uniformed Services University Of The Health Sciences Bethesda United States

Personal Author(s) : Alston,Teresita L

Full Text :

Report Date : 01 Jun 2015

Pagination or Media Count : 99

Abstract : Combination therapy, in guided tissue regeneration (GTR), is often used in the treatment of intrabony defects. Particulate demineralized freeze- dried bone allograft (DFDBA) is a bone grafting materials used successfully in GTR on humans for almost 30 years. A newer form of DFDBA, Accell Connexus (Accell), has been FDA approved for use in periodontal regeneration which is the growth of new bone, cementum and periodontal ligament on a previously diseased tooth root surface. Accell Connexus contains 5-7 times more bone morphogenic proteins (BMP) than the traditional particulate DFDBA. This increase in BMP is thought to increase the potential of periodontal regeneration.

Descriptors :   GRAFTS , Regeneration (Physiology) , Dental surgery

Distribution Statement : APPROVED FOR PUBLIC RELEASE